Aurinia Pharmaceuticals
- Biotech or pharma, therapeutic R&D
Aurinia is a fully integrated biopharmaceutical company that recently introduced the first FDA-approved oral therapy indicated for the treatment of adult patients with active lupus nephritis. We are also developing AUR200, a dual BAFF/APRIL inhibitor, for the potential treatment of autoimmune disease
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}